Len Heflich
Specialist in the Global Food Industry, focusing on Risk Management, Business Assessment, Development of Strategic Capabilities and Practical Compliance.
Full Bio
by Len Heflich | Nov 19, 2019
“Conclusions: C60 and derivatives have shown successful applications in intensive biomedical research due to their unparalleled physical and chemical properties.” Click here to view the Word File:...
by Len Heflich | Nov 15, 2019
Debora MacKenzie, New Scientist, 10 August 2019, pages 42-46 FOR decades, health experts have been lecturing us about our bad habits, blaming them for the surge in “lifestyle diseases”. These often come on as we age and include heart disease, Alzheimer’s, type 2...
by Len Heflich | Nov 8, 2018
Inflammation is the main reason or accompanying phenomenon almost of all gut disorders, and its elimination is required tor successful therapy. A significant role at all the stages of inflammation and carcinogenesis is attributed to reactive oxygen species...
by Len Heflich | Nov 8, 2018
Quantum mechanical calculations of binding energy of the C60−OH adduct as a function of C60 clustering degree indicate, despite an initial fast reaction, a slower overall conversion due to thermodynamic instability of C60−OH intermediates. The results imply that...
by Len Heflich | Oct 22, 2018
The emerging field of nanotechnology is affirming its increasing importance day by day. In this context fullerenes and carbon nanotubes (CNTs) play an important role. These new allotropic forms of carbon have been discovered in the last two decades, and, since then,...
